Chasing the "Holy Grail": Modulating Neutrophils in Inflammatory Lung Disease
- PMID: 30865833
- PMCID: PMC6635790
- DOI: 10.1164/rccm.201902-0333ED
Chasing the "Holy Grail": Modulating Neutrophils in Inflammatory Lung Disease
Comment on
-
IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses In Vivo.Am J Respir Crit Care Med. 2019 Jul 15;200(2):235-246. doi: 10.1164/rccm.201808-1599OC. Am J Respir Crit Care Med. 2019. PMID: 30849228 Free PMC article.
References
-
- Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788–800. [Published erratum appears in JAMA 316:350.] - PubMed
-
- Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, et al. Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293–1304. - PubMed
-
- Bachofen M, Weibel ER. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis. 1977;116:589–615. - PubMed
-
- Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care. 2001;7:1–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
